Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 6:25 AM ET


Company Overview of Cambridge Biotechnology Limited

Executive Profile

Michael Skynner Ph.d.

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 0 different industries.



Mr. Michael Skynner, Ph.d., was the founder of Cambridge Biotechnology Limited (CBT) and served as its Head of Molecular & Cellular Biology. Mr. Skynner is an expert in molecular neurobiology and is the inventor of "micro-expression profiling", a patented CBT technology for identifying and validating novel drug targets through the amplification of mRNA from single cells. Before joining CBT, he worked in the molecular neuroscience group at Parke-Davis/Pfizer.

Corporate Headquarters

Babraham Research Campus
Cambridge, Cambridgeshire CB22 3AT

United Kingdom

Phone: 44 1223 497300
Fax: 44 1223 839521

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cambridge Biotechnology Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at